ArticleInternational journal of endocrinology2026
Comparative Efficacy of Two-Session Radiofrequency Ablation Versus Transarterial Embolization Followed by Radiofrequency Ablation for the Treatment of Large Benign Thyroid Nodules.
Article in International journal of endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative Efficacy of Two-Session Radiofrequency Ablation Versus Transarterial Embolization Followed by Radiofrequency Ablation for the Treatment of Large Benign Thyroid Nodules.International journal of endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purposes: To treat large benign thyroid nodules (BTNs), radiofrequency ablation (RFA) and transarterial embolization (TAE) combined with RFA are both used. This study aimed to compare the effectiveness of both treatments. Methods: Nineteen subjects with 20 BTNs received two sessions of RFA, while eight patients with 10 BTNs underwent TAE followed by RFA in a single medical center. Propensity score matching (PSM) was utilized to control for inherent potential biases by matching similar characteristics between the two groups. Results: Prior to treatment, a larger median nodule volume was observed in the TAE with the RFA group (150.75 ± 202.61 mL) compared to that of the double-session RFA group (81.44 ± 58.00 mL). The volume reduction ratio (VRR) was found to be 74.60 ± 14.49% in the TAE/RFA group and 83.93 ± 12.70% in the double-session RFA group. To account for follow-up duration, we calculated the variation of VRR (ΔVRR, %) divided by the follow-up time in days. The TAE with the RFA group showed a median reduction of 0.17 ± 0.05%/day, while the double-session RFA group showed 0.13 ± 0.05%/day, with a Conclusions: Our findings suggest that TAE combined with RFA may be a more effective treatment option for large BTNs compared to two sessions of RFA alone, thus providing an alternative treatment approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.